Latest Insider Transactions at Invitae Corp (NVTA)
This section provides a real-time view of insider transactions for Invitae Corp (NVTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Invitae Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Invitae Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2023
|
Robert L Nussbaum Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,404
-3.06%
|
$0
$0.65 P/Share
|
|
Dec 20
2023
|
Thomas Brida |
SELL
Payment of exercise price or tax liability
|
Direct |
17,404
-1.86%
|
$0
$0.65 P/Share
|
|
Nov 13
2023
|
David Sholehvar Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
850,000
+50.0%
|
-
|
|
Oct 18
2023
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
229,500
+19.73%
|
-
|
|
Oct 02
2023
|
Ana J. Schrank Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
850,000
+50.0%
|
-
|
|
Sep 23
2023
|
Robert M. Guigley Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
850,000
+50.0%
|
-
|
|
Jun 13
2023
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
7,079
-1.0%
|
$7,079
$1.38 P/Share
|
|
Jun 13
2023
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,086
-1.23%
|
$7,086
$1.38 P/Share
|
|
May 16
2023
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
45,432
-2.65%
|
$45,432
$1.2 P/Share
|
|
May 16
2023
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
21,559
-5.73%
|
$21,559
$1.2 P/Share
|
|
May 16
2023
|
Yafei Wen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,452
-5.84%
|
$43,452
$1.99 P/Share
|
|
May 16
2023
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,476
-4.39%
|
$26,476
$1.2 P/Share
|
|
May 16
2023
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
26,476
-3.59%
|
$26,476
$1.2 P/Share
|
|
Apr 27
2023
|
Randal W. Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+30.4%
|
-
|
|
Apr 27
2023
|
Chitra Nayak Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+38.81%
|
-
|
|
Apr 27
2023
|
Eric Aguiar Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+35.98%
|
-
|
|
Apr 27
2023
|
Christine Marie Gorjanc Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+38.81%
|
-
|
|
Apr 27
2023
|
William H Osborne Director |
BUY
Grant, award, or other acquisition
|
Direct |
88,027
+21.67%
|
-
|
|
Apr 27
2023
|
Kimber D Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+38.81%
|
-
|
|
Apr 27
2023
|
Geoffrey Crouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,422
+35.09%
|
-
|
|
Apr 03
2023
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+28.91%
|
-
|
|
Apr 03
2023
|
Yafei Wen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+28.74%
|
-
|
|
Apr 03
2023
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+24.42%
|
-
|
|
Apr 03
2023
|
Kenneth D. Knight Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+41.14%
|
-
|
|
Apr 03
2023
|
Robert L Nussbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,000
+20.45%
|
-
|
|
Mar 13
2023
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
2,625
-0.6%
|
$2,625
$1.41 P/Share
|
|
Mar 13
2023
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,853
-0.36%
|
$1,853
$1.41 P/Share
|
|
Mar 13
2023
|
Yafei Wen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,625
-0.59%
|
$2,625
$1.41 P/Share
|
|
Mar 13
2023
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,625
-0.58%
|
$2,625
$1.41 P/Share
|
|
Jan 26
2023
|
William H Osborne Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,423
+50.0%
|
-
|
|
Dec 19
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
11,163
-1.5%
|
$22,326
$2.08 P/Share
|
|
Dec 16
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
44,816
-5.68%
|
$89,632
$2.04 P/Share
|
|
Aug 25
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,350
-0.53%
|
$4,050
$3.45 P/Share
|
|
Aug 22
2022
|
Robert L Nussbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+10.7%
|
-
|
|
Aug 22
2022
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+17.61%
|
-
|
|
Aug 22
2022
|
Yafei Wen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,000
+18.6%
|
-
|
|
Aug 22
2022
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+10.93%
|
-
|
|
Aug 16
2022
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,048
-1.75%
|
$28,192
$4.55 P/Share
|
|
Aug 16
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,252
-1.61%
|
$13,008
$4.55 P/Share
|
|
Aug 16
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
22,085
-2.72%
|
$88,340
$4.55 P/Share
|
|
Aug 16
2022
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
7,048
-1.79%
|
$28,192
$4.55 P/Share
|
|
Jul 17
2022
|
Sean E George Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,050
+1.94%
|
-
|
|
Jul 16
2022
|
Randal W. Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,800
+22.02%
|
-
|
|
May 19
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,746
-1.34%
|
$8,238
$3.4 P/Share
|
|
May 17
2022
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,098
-1.49%
|
$18,294
$3.81 P/Share
|
|
May 17
2022
|
Yafei Wen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,042
-4.72%
|
$51,126
$3.81 P/Share
|
|
May 17
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
18,296
-2.25%
|
$54,888
$3.81 P/Share
|
|
May 17
2022
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
6,098
-1.53%
|
$18,294
$3.81 P/Share
|
|
May 17
2022
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,295
-5.17%
|
$84,885
$3.81 P/Share
|
|
May 17
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,356
-3.47%
|
$22,068
$3.81 P/Share
|